VerAvanti logo

VerAvanti

Website

Team & Investors

Leadership, board of directors, and investment partners

Executives
0
Board Members
0
Investors
6
Total Funding
$38.4M
Investors
6 investors across all rounds
AB
and Blood Institute
L
Lung
NC
National Cancer Institute
NH
National Heart
UO
University of Washington

+1 more investors

Sign in to view all

Explore More Data
Detailed analysis for VerAvanti

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

VerAvanti Leadership & Investors

VerAvanti is led by a team of experienced leaders. The company has attracted investment from 6 institutional and strategic investors.

Who Has Invested in VerAvanti?

VerAvanti has raised $38.4M from 6 investors including venture capital firms, private equity investors, and strategic partners.

Investment Opportunity

Accredited investors can access VerAvanti shares through secondary market platforms like Premier Alternatives, joining the company's existing institutional investor base.